MMP11 and prostate carcinoma: The MMP-11 SNPs, including the rs131451, have shown no impact on uterine cervical cancer in Taiwanese women [52], whereas the MMP-11 rs131451 “TC + CC” polymorphic variants were correlated with advanced clinical stage (T stage; p = 0.007) and high-risk D’Amico classification (p = 0.015) in prostate cancer patients with biochemical recurrence [37].